Literature DB >> 17204863

The regulation of energy generating metabolic pathways by p53.

Chad A Corcoran1, Ying Huang, M Saeed Sheikh.   

Abstract

The function of p53 as a tumor suppressor remains undisputed. p53 has a central role in cellular stress responses as well as affecting cancer development and progression. The word "central", however, is becoming increasingly more of an understatement as the list of p53-regulated pathways and processes is ever expanding. Although much focus continues to center on p53-mediated signaling cascades that control cell growth arrest and/or apoptosis, recent work has begun to define a role for p53 in the regulation of metabolic pathways typically thought of as essential for maintaining life. With the first potential link between p53 and glycolysis reported nearly ten years ago, the topic has gained a renewed interest. Recent studies now demonstrate the ability of p53 to regulate the expression of several novel genes including PGM (phosphoglycerate mutase), TIGAR (TP53-induced glycolysis and apoptosis regulator) and, SCO2 (synthesis of cytochrome c oxidase 2), each intimately linked to the processes of glycolysis and oxidative phosphorylation. With this discovery, yet another novel means by which p53 carries out its tumor suppressor function is brought into light.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17204863     DOI: 10.4161/cbt.5.12.3617

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

1.  AMP-activated protein kinase promotes human prostate cancer cell growth and survival.

Authors:  Hyeon Ung Park; Simeng Suy; Malika Danner; Vernon Dailey; Ying Zhang; Henghong Li; Daniel R Hyduke; Brian T Collins; Gregory Gagnon; Bhaskar Kallakury; Deepak Kumar; Milton L Brown; Albert Fornace; Anatoly Dritschilo; Sean P Collins
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

2.  Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.

Authors:  Yao-An Shen; Wai-Hou Li; Po-Hung Chen; Chun-Lin He; Yen-Hou Chang; Chi-Mu Chuang
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  p53 is required for chloroquine-induced atheroprotection but not insulin sensitization.

Authors:  Babak Razani; Chu Feng; Clay F Semenkovich
Journal:  J Lipid Res       Date:  2010-03-05       Impact factor: 5.922

Review 4.  Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept.

Authors:  Vladimir N Uversky
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

Review 5.  Stress eating and tuning out: cancer cells re-wire metabolism to counter stress.

Authors:  Zachary E Stine; Chi V Dang
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

6.  Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

Authors:  Taro Hitosugi; Lu Zhou; Shannon Elf; Jun Fan; Hee-Bum Kang; Jae Ho Seo; Changliang Shan; Qing Dai; Liang Zhang; Jianxin Xie; Ting-Lei Gu; Peng Jin; Masa Alečković; Gary LeRoy; Yibin Kang; Jessica A Sudderth; Ralph J DeBerardinis; Chi-Hao Luan; Georgia Z Chen; Susan Muller; Dong M Shin; Taofeek K Owonikoko; Sagar Lonial; Martha L Arellano; Hanna J Khoury; Fadlo R Khuri; Benjamin H Lee; Keqiang Ye; Titus J Boggon; Sumin Kang; Chuan He; Jing Chen
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

Review 7.  Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.

Authors:  Ivan A Olovnikov; Julia E Kravchenko; Peter M Chumakov
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

Review 8.  Watching the watcher: regulation of p53 by mitochondria.

Authors:  Aaron K Holley; Daret K St Clair
Journal:  Future Oncol       Date:  2009-02       Impact factor: 3.404

Review 9.  Targeting glucose metabolism in patients with cancer.

Authors:  Shannon E Elf; Jing Chen
Journal:  Cancer       Date:  2013-12-02       Impact factor: 6.860

10.  Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.

Authors:  Taro Hitosugi; Lu Zhou; Jun Fan; Shannon Elf; Liang Zhang; Jianxin Xie; Yi Wang; Ting-Lei Gu; Masa Alečković; Gary LeRoy; Yibin Kang; Hee-Bum Kang; Jae-Ho Seo; Changliang Shan; Peng Jin; Weimin Gong; Sagar Lonial; Martha L Arellano; Hanna J Khoury; Georgia Z Chen; Dong M Shin; Fadlo R Khuri; Titus J Boggon; Sumin Kang; Chuan He; Jing Chen
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.